Frost & Sullivan Recognizes Baxano Surgical As A Leader in MIS Spine Innovation
Based on its recent analysis of the minimally invasive spinal surgical solutions market, Frost & Sullivan recognizes Baxano Surgical, Inc. with the 2014 North American Frost & Sullivan Award for Product Line Strategy Leadership. Baxano Surgical’s superior products facilitate minimally invasive surgery (MIS), offering both patients and hospitals reliable and easy-to-use products that improve outcomes for medical conditions that affect the lumbar region of the spine.
Baxano Surgical’s products include AxiaLIF, VEO, iO-Flex, and the AVANCE MIS Pedicle Screw System. The AxiaLIF system provides a minimally invasive alternative to open spinal fusion procedures, while the VEO Lateral Access and Interbody Fusion System helps surgeons to better visualize the surgical area through clear radiographic views and simultaneously provides a nerve monitoring mechanism.
Baxano Surgical’s iO-Flex is specifically designed to treat lumbar spinal stenosis caused by the overgrowth of bone and tissue in the vertebra. It uses a fine wire that allows surgeons to shave away the overgrown tissue without cutting into healthy tissue. Finally, the AVANCE MIS Pedicle Screw System, which provides posterior fixation of the spine, is designed to minimize tissue damage, while eliminating the need for additional incisions to insert a rod.
“Frost & Sullivan finds that with the expansion of its portfolio to include VEO, iO-Flex and AVANCE, Baxano’s product line covers at least half of the spine surgery device needs of hospitals involved in treating degenerative disc disease,” said Frost & Sullivan Consultant Imran Khan. “Baxano Surgical recognizes the need for further additions to its portfolio and continues to invest in its research and development division.”
Furthermore, Baxano Surgical provides a robust training platform to educate surgeons on product utilization and functionality. By providing hands-on experience, surgeons are able to develop practical techniques with a focus on lateral and presacral fusion approaches as well as decompression with the iO-Flex microblade shaver.
“The cost-efficient nature of Baxano’s MIS products creates value for the payers in the form of a lower overall cost of treatment through less recovery time, shorter hospital stay, and reduced need for excessive pain medicine,” noted Khan. “They also benefit hospitals as they aid in resource optimization, demonstrating significant overall value to the healthcare industry.”
Each year, Frost & Sullivan presents this award to the company that has developed a comprehensive product line that caters to the breadth of the market it serves. The award recognizes the extent to which the product line meets customer base demands, the overall impact it has in terms of customer value, as well as increased market share.
Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.
About Baxano Surgical
Baxano Surgical, Inc. (baxanosurgical.com) is a medical device company focused on designing, developing, and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. Baxano Surgical currently markets the AxiaLIF® family of products for single and two-level lower lumbar fusion; the VEO® lateral access and interbody fusion system; the iO-Flex® system, a proprietary set of flexible instruments used by surgeons during spinal decompression procedures; the iO-Tome® instrument, which rapidly and precisely removes bone, specifically the facet joints, which is commonly performed in spinal fusion procedures; and Avance™, a MIS pedicle screw system used in lumbar fusion procedures. Baxano Surgical was founded in May 2000 and is headquartered in Raleigh, North Carolina.
AxiaLIF, VEO, iO-Tome and iO-Flex are all registered trademarks of Baxano Surgical.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?